{"entity":{"type":"insider","cik":"0001598640","url":"/insider/0001598640","json_url":"/insider/0001598640.json","name":"Dumas Jacques","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":6,"first":"2017-08-21","last":"2019-01-10","span_basis":"filed_date"},"name_variants":[{"name":"Dumas Jacques","source":"filing","n_filings":6,"first_seen":"2017-08-21","last_seen":"2019-01-10"}],"transactions":[{"id":7920237,"accession":"0001209191-19-003290","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-003290","line_url":"/filing/0001209191-19-003290#line-1","is_derivative":false,"issuer_cik":"0001373707","issuer_name":"TETRAPHASE PHARMACEUTICALS INC","issuer_ticker":"TTPH","issuer_name_source":null,"issuer_url":"/issuer/0001373707","owner_cik":"0001598640","owner_name":"Dumas Jacques","owner_url":"/insider/0001598640","role":"Officer (Chief ScientificOfficer)","officer_title":"Chief ScientificOfficer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7497.0,"shares_display":"7,497","price_per_share":1.6,"price_display":"1.60","price_state":"stated","total_value":11995.2,"total_display":"11,995.20","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-08","filed_date":"2019-01-10","scope":"insider"},{"id":6075083,"accession":"0001209191-18-006210","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-006210","line_url":"/filing/0001209191-18-006210#line-2","is_derivative":false,"issuer_cik":"0001373707","issuer_name":"TETRAPHASE PHARMACEUTICALS INC","issuer_ticker":"TTPH","issuer_name_source":null,"issuer_url":"/issuer/0001373707","owner_cik":"0001598640","owner_name":"Dumas Jacques","owner_url":"/insider/0001598640","role":"Officer (Chief ScientificOfficer)","officer_title":"Chief ScientificOfficer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8750.0,"shares_display":"8,750","price_per_share":6.22,"price_display":"6.22","price_state":"stated","total_value":54425.0,"total_display":"54,425.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-30","filed_date":"2018-01-31","scope":"insider"},{"id":6321450,"accession":"0001209191-18-003253","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-003253","line_url":"/filing/0001209191-18-003253#line-1","is_derivative":false,"issuer_cik":"0001373707","issuer_name":"TETRAPHASE PHARMACEUTICALS INC","issuer_ticker":"TTPH","issuer_name_source":null,"issuer_url":"/issuer/0001373707","owner_cik":"0001598640","owner_name":"Dumas Jacques","owner_url":"/insider/0001598640","role":"Officer (Chief ScientificOfficer)","officer_title":"Chief ScientificOfficer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7167.0,"shares_display":"7,167","price_per_share":6.21,"price_display":"6.21","price_state":"stated","total_value":44507.07,"total_display":"44,507.07","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-09","filed_date":"2018-01-11","scope":"insider"},{"id":4711692,"accession":"0001209191-17-058940","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-058940","line_url":"/filing/0001209191-17-058940#line-2","is_derivative":false,"issuer_cik":"0001373707","issuer_name":"TETRAPHASE PHARMACEUTICALS INC","issuer_ticker":"TTPH","issuer_name_source":null,"issuer_url":"/issuer/0001373707","owner_cik":"0001598640","owner_name":"Dumas Jacques","owner_url":"/insider/0001598640","role":"Officer (Chief ScientificOfficer)","officer_title":"Chief ScientificOfficer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8750.0,"shares_display":"8,750","price_per_share":6.03,"price_display":"6.03","price_state":"stated","total_value":52762.5,"total_display":"52,762.50","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-31","filed_date":"2017-11-02","scope":"insider"},{"id":4991192,"accession":"0001209191-17-050140","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-050140","line_url":"/filing/0001209191-17-050140#line-2","is_derivative":false,"issuer_cik":"0001373707","issuer_name":"TETRAPHASE PHARMACEUTICALS INC","issuer_ticker":"TTPH","issuer_name_source":null,"issuer_url":"/issuer/0001373707","owner_cik":"0001598640","owner_name":"Dumas Jacques","owner_url":"/insider/0001598640","role":"Officer (Chief ScientificOfficer)","officer_title":"Chief ScientificOfficer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17500.0,"shares_display":"17,500","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":105000.0,"total_display":"105,000.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-22","filed_date":"2017-08-24","scope":"insider"},{"id":4944919,"accession":"0001209191-17-049702","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-049702","line_url":"/filing/0001209191-17-049702#line-1","is_derivative":false,"issuer_cik":"0001373707","issuer_name":"TETRAPHASE PHARMACEUTICALS INC","issuer_ticker":"TTPH","issuer_name_source":null,"issuer_url":"/issuer/0001373707","owner_cik":"0001598640","owner_name":"Dumas Jacques","owner_url":"/insider/0001598640","role":"Officer (Chief ScientificOfficer)","officer_title":"Chief ScientificOfficer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7155.0,"shares_display":"7,155","price_per_share":5.86,"price_display":"5.86","price_state":"stated","total_value":41928.3,"total_display":"41,928.30","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-17","filed_date":"2017-08-21","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001373707","name":"TETRAPHASE PHARMACEUTICALS INC","url":"/issuer/0001373707","role":"Officer (Chief ScientificOfficer)","n_filings":6,"first_seen":"2017-08-21","last_seen":"2019-01-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001598640","retrieved_at":"2026-08-20T22:14:46+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}